Feline panleukopenia virus (FPV) is a highly contagious pathogen that can cause severe disease, particularly in young kittens. We developed a proof-of-concept antigen-delivery strategy using adipose-derived mesenchymal stem cells (ADSCs) engineered to express and secrete FPV VP2 protein. Lentiviral transduction achieved stable VP2 expression without measurably impairing ADSCs proliferation or migration under the conditions tested. In vivo imaging in mice showed that engineered ADSCs remained detectable at the injection site for approximately 21 days. In mice, ADSC-VP2 administration induced FPV-specific IgG, neutralizing antibody responses, lymphocyte proliferation, and cytokine changes. In five volunteer cats vaccinated on days 0, 21, and 42, FPV-specific antibody titers and PRNT_50 activity remained detectable through 180 days. PBMC assays showed stimulation-index and cytokine responses after in vitro restimulation with VP2 or inactivated FPV, and immune sera qualitatively inhibited FPV-associated cytopathic changes in CRFK cells. Longitudinal complete blood counts and serum biochemical measurements showed no overt clinically relevant abnormalities during the 180-day observation period. These findings support ADSC-VP2 as a proof-of-concept cell-based antigen-delivery platform, protective efficacy remains to be established in controlled FPV challenge studies. Graphical abstract
Yang, Haoyan, Yang, Lirong, Zhao, Yaohui et al. Development and evaluation of a cell-based vaccine expressing VP2 for feline panleukopenia control. // Stem Cell Research & Therapy. – 2026. – DOI: 10.1186/s13287-026-05391-w. – URL: https://doi.org/10.1186/s13287-026-05391-w
Yang, Haoyan, Yang, Lirong, Zhao, Yaohui, Zhao, Yaguan, Li, Balun, Li, Na, Du, Taofeng, Hua, & Jinlian (2026). Development and evaluation of a cell-based vaccine expressing VP2 for feline panleukopenia control. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-026-05391-w
Yang, et al. “Development and evaluation of a cell-based vaccine expressing VP2 for feline panleukopenia control.” Stem Cell Research & Therapy, 2026. doi:10.1186/s13287-026-05391-w.
@article{Yang2026,
title = {Development and evaluation of a cell-based vaccine expressing VP2 for feline panleukopenia control},
author = {Yang and Haoyan and Yang and Lirong and Zhao and Yaohui and Zhao and Yaguan and Li and Balun and Li and Na and Du and Taofeng and Hua and Jinlian},
journal = {Stem Cell Research \& Therapy},
year = {2026},
doi = {10.1186/s13287-026-05391-w},
url = {https://doi.org/10.1186/s13287-026-05391-w}
}
Background Human liver organoids are useful for modeling steatotic liver injury and exploring disease-related mechanisms. This study examined the role of negative elongation factor E (NELFE) in metabolic dysfunction-associated steatotic...
Dysfunctional Epicardial adipose tissue (EAT), a specific beige/brown-like fat depot predominantly present in humans, is associated with coronary artery disease, atrial fibrillation and impaired systolic function. On the molecular...
Allometric growth is a key factor in understanding morphological development and biomass allocation in marine invertebrates. In crustaceans, growth is typically non-isometric, with mass scaling disproportionately with body size across...
The progression of malignancy depends entirely on profound restructuring of cells metabolic framework, allowing tumors to bypass physiological limitations while sustaining constant anabolic growth. Alteration of metabolic networks...
The discovery of induced pluripotent stem cells (iPSC) was met with optimism that this new technology would revolutionize how we model and treat human diseases. The last 20 years of research, however, has somewhat tempered the initial...